Cargando…
Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
Background: Medullary thyroid carcinoma (MTC) is a relatively rare and aggressive form of thyroid malignancy arising from parafollicular cells. The biochemical hallmark of MTC is elevated serum calcitonin (CTN), which aids initial diagnosis and disease surveillance. An atypical form of calcitonin no...
Autores principales: | Oleinikov, Kira, Grozinsky-Glasberg, Simona, Atlan, Karine, Maimon, Ofra, Popovtzer, Aron, Weinberger, Jeffrey M, Hirshoren, Nir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089971/ http://dx.doi.org/10.1210/jendso/bvab048.1806 |
Ejemplares similares
-
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
por: Arnon, Johnathan, et al.
Publicado: (2022) -
The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021) -
ODP466 Case of Sporadic Medullary Thyroid Cancer Detected by Serum Calcitonin Measurement
por: Juneau, Andrea Kate, et al.
Publicado: (2022) -
SAT560 A Case of Medullary Thyroid Carcinoma with Increasing Carcinoembryonic Antigen and Stable Calcitonin Levels
por: Youssef, Kerolos N, et al.
Publicado: (2023) -
Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma
por: DE CREA, C., et al.
Publicado: (2014)